BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MLLT4, ENSG00000130396, 4301
18 results:

  • 1. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
    Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
    Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A thirteen‑gene set efficiently predicts the prognosis of glioblastoma.
    Yang H; Jin L; Sun X
    Mol Med Rep; 2019 Mar; 19(3):1613-1621. PubMed ID: 30628650
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia.
    Chen X; Wang F; Zhang Y; Wang M; Tian W; Teng W; Ma X; Guo L; Fang J; Zhang Y; Zhu P; Liu H
    Leuk Res; 2018 Sep; 72():99-104. PubMed ID: 30125757
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
    Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
    Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse.
    Higuchi Y; Tokunaga K; Watanabe Y; Kawakita T; Harada N; Yamaguchi S; Nosaka K; Mitsuya H; Asou N
    Cancer Genet; 2016 Jun; 209(6):267-71. PubMed ID: 27268298
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cytogenetic and molecular profile of endometrial stromal sarcoma.
    Micci F; Gorunova L; Agostini A; Johannessen LE; Brunetti M; Davidson B; Heim S; Panagopoulos I
    Genes Chromosomes Cancer; 2016 Nov; 55(11):834-46. PubMed ID: 27219024
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Bioinformatic analysis of chronic myeloid leukemia progression and preliminary experimental verification].
    Zhang JF; Liu XL; Lin YD; Pan JW; Xu N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):909-13. PubMed ID: 25130802
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FISH analysis of MLL gene rearrangements: detection of the concurrent loss or gain of the 3' signal and its prognostic significance.
    Lim JH; Jang S; Park CJ; Chi HS; Lee JO; Seo EJ
    Int J Lab Hematol; 2014 Oct; 36(5):571-9. PubMed ID: 24612538
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
    Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The MLL recombinome of acute leukemias in 2013.
    Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Rapid detection of prognostically significant fusion transcripts in acute leukemia using simplified multiplex reverse transcription polymerase chain reaction.
    Cho YU; Chi HS; Park CJ; Jang S; Seo EJ
    J Korean Med Sci; 2012 Oct; 27(10):1155-61. PubMed ID: 23091311
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
    Cerveira N; Lisboa S; Correia C; Bizarro S; Santos J; Torres L; Vieira J; Barros-Silva JD; Pereira D; Moreira C; Meyer C; Oliva T; Moreira I; Martins Â; Viterbo L; Costa V; Marschalek R; Pinto A; Mariz JM; Teixeira MR
    Mol Oncol; 2012 Oct; 6(5):553-64. PubMed ID: 22846743
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners.
    Keefe JG; Sukov WR; Knudson RA; Nguyen LP; Williamson C; Sinnwell JP; Ketterling RP
    J Mol Diagn; 2010 Jul; 12(4):441-52. PubMed ID: 20539022
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. New insights to the MLL recombinome of acute leukemias.
    Meyer C; Kowarz E; Hofmann J; Renneville A; Zuna J; Trka J; Ben Abdelali R; Macintyre E; De Braekeleer E; De Braekeleer M; Delabesse E; de Oliveira MP; Cavé H; Clappier E; van Dongen JJ; Balgobind BV; van den Heuvel-Eibrink MM; Beverloo HB; Panzer-Grümayer R; Teigler-Schlegel A; Harbott J; Kjeldsen E; Schnittger S; Koehl U; Gruhn B; Heidenreich O; Chan LC; Yip SF; Krzywinski M; Eckert C; Möricke A; Schrappe M; Alonso CN; Schäfer BW; Krauter J; Lee DA; Zur Stadt U; Te Kronnie G; Sutton R; Izraeli S; Trakhtenbrot L; Lo Nigro L; Tsaur G; Fechina L; Szczepanski T; Strehl S; Ilencikova D; Molkentin M; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2009 Aug; 23(8):1490-9. PubMed ID: 19262598
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BglII-based panhandle and reverse panhandle PCR approaches increase capability for cloning der(II) and der(other) genomic breakpoint junctions of MLL translocations.
    Robinson BW; Slater DJ; Felix CA
    Genes Chromosomes Cancer; 2006 Aug; 45(8):740-53. PubMed ID: 16703585
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
    Hemminki K; Jiang Y; Steineck G
    Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.